-
1
المؤلفون: Pascale Exer, Giorgio Tamborrini, Pascal Zufferey, Burkhard Möller, Adrian Ciurea, Monika Hebeisen, Michael John Nissen, Raphael Micheroli, Almut Scherer
المساهمون: University of Zurich, Ciurea, Adrian
المصدر: PLoS ONE
PloS one, vol. 14, no. 5, pp. e0216746
PLoS ONE, Vol 14, Iss 5, p e0216746 (2019)
Hebeisen, Monika; Scherer, Almut; Micheroli, Raphael; Nissen, Michael J; Tamborrini, Giorgio; Möller, Burkhard; Zufferey, Pascal; Exer, Pascale; Ciurea, Adrian (2019). Comparison of drug survival on adalimumab, etanercept, golimumab and infliximab in patients with axial spondyloarthritis. PLoS ONE, 14(5), e0216746. Public Library of Science 10.1371/journal.pone.0216746 <http://dx.doi.org/10.1371/journal.pone.0216746>
PLOS ONE, Vol. 14, No 5 (2019) P. e0216746مصطلحات موضوعية: Male, Time Factors, Physiology, medicine.medical_treatment, Ankylosing Spondylitis, Cancer Treatment, Biochemistry, Etanercept, White Blood Cells, Animal Cells, Immune Physiology, Medicine and Health Sciences, 610 Medicine & health, ddc:616, Innate Immune System, Multidisciplinary, Pharmaceutics, Hazard ratio, Anti-Inflammatory Agents, Non-Steroidal, 10051 Rheumatology Clinic and Institute of Physical Medicine, Antibodies, Monoclonal, Middle Aged, C-Reactive Proteins, TNF inhibitor, Oncology, Antirheumatic Agents, Medicine, Cytokines, Female, Cellular Types, medicine.drug, Research Article, Adult, musculoskeletal diseases, medicine.medical_specialty, Drug Synthesis, Science, Immune Cells, Immunology, 1100 General Agricultural and Biological Sciences, Gastroenterology and Hepatology, Autoimmune Diseases, Drug Therapy, 1300 General Biochemistry, Genetics and Molecular Biology, Internal medicine, Adalimumab/administration & dosage, Anti-Inflammatory Agents, Non-Steroidal/administration & dosage, Antibodies, Monoclonal/administration & dosage, Antirheumatic Agents/administration & dosage, Etanercept/administration & dosage, Humans, Infliximab/administration & dosage, Spondylarthritis/drug therapy, Tumor Necrosis Factor Inhibitors/administration & dosage, Spondylarthritis, Adalimumab, medicine, Ankylosing spondylitis, 1000 Multidisciplinary, Blood Cells, Proportional hazards model, business.industry, Pharmaceutical Processing Technology, Inflammatory Bowel Disease, Biology and Life Sciences, Proteins, Cell Biology, Molecular Development, medicine.disease, Golimumab, Infliximab, Immune System, 570 Life sciences, biology, Clinical Immunology, Tumor Necrosis Factor Inhibitors, Clinical Medicine, business, Developmental Biology
وصف الملف: pone.0216746.pdf - application/pdf; application/pdf
-
2
المؤلفون: Pascale Exer, Rudolf O. Kissling, Ulrich Weber, Beat A. Michel, Peter M. Villiger, Martin Toniolo, Almut Scherer, Adrian Ciurea, Jürg Bernhard, Pascal Zufferey, Daniel J. Stekhoven, Giorgio Tamborrini
المساهمون: University of Zurich, Ciurea, Adrian
المصدر: Ciurea, A, Weber, U, Stekhoven, D, Scherer, A, Tamborrini, G, Bernhard, J, Toniolo, M, Villiger, P M, Zufferey, P, Kissling, R O, Michel, B A & Exer, P 2015, ' Treatment with tumor necrosis factor inhibitors in axial spondyloarthritis : Comparison between private rheumatology practices and academic centers in a large observational cohort ', Journal of Rheumatology, vol. 42, no. 1, pp. 101-105 . https://doi.org/10.3899/jrheum.140229
مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, 2745 Rheumatology, Immunology, Private Practice, 610 Medicine & health, Antirheumatic Agents/therapeutic use, Rheumatology, Internal medicine, Spondylarthritis, Humans, Immunology and Allergy, Medicine, Practice Patterns, Physicians', Axial spondyloarthritis, BASDAI, Spondylarthritis/drug therapy, 2403 Immunology, Academic Medical Centers, Ankylosing spondylitis, Tumor Necrosis Factor-alpha/antagonists & inhibitors, Tumor Necrosis Factor-alpha, business.industry, 10051 Rheumatology Clinic and Institute of Physical Medicine, Middle Aged, medicine.disease, University hospital, adult ankylosing spondylitis Ankylosing Spondylitis Disease Activity Score article cohort analysis *comparative study controlled study female follow up functional assessment human major clinical study male middle aged observational study *private hospital *spondylarthritis/dt [Drug Therapy] treatment indication treatment outcome treatment response *university hospital disease modifying antirheumatic drug/dt [Drug Therapy] nonsteroid antiinflammatory agent/dt [Drug Therapy] *tumor necrosis factor inhibitor/dt [Drug Therapy], Treatment Outcome, Antirheumatic Agents, Cohort, 2723 Immunology and Allergy, Physical therapy, 10046 Balgrist University Hospital, Swiss Spinal Cord Injury Center, Female, Tumor necrosis factor alpha, Observational study, business
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb400ecdefcf2a6b238cc093810195c8
https://doi.org/10.3899/jrheum.140229 -
3
المؤلفون: Raphael Micheroli, Monika Hebeisen, Lukas M. Wildi, Pascale Exer, Giorgio Tamborrini, Jürg Bernhard, Burkhard Möller, Pascal Zufferey, Michael J. Nissen, Almut Scherer, Adrian Ciurea, on behalf of the Rheumatologists of the Swiss Clinical Quality Management Program
المساهمون: University of Zurich, Ciurea, Adrian, Rheumatologists of the Swiss Clinical Quality Management Program
المصدر: Arthritis Research and Therapy, Vol. 19, No 1 (2017) P. 164
Micheroli, Raphael; Hebeisen, Monika; Wildi, Lukas M.; Exer, Pascale; Tamborrini, Giorgio; Bernhard, Jürg; Möller, Burkhard; Zufferey, Pascal; Nissen, Michael J.; Scherer, Almut; Ciurea, Adrian (2017). Impact of obesity on the response to tumor necrosis factor inhibitors in axial spondyloarthritis. Arthritis research & therapy, 19(1), p. 164. BioMed Central 10.1186/s13075-017-1372-3 <http://dx.doi.org/10.1186/s13075-017-1372-3>
Arthritis research & therapy, vol. 19, no. 1, pp. 164
Arthritis Research & Therapy
Arthritis Research & Therapy, Vol 19, Iss 1, Pp 1-8 (2017)مصطلحات موضوعية: 0301 basic medicine, Adult, Male, medicine.medical_specialty, lcsh:Diseases of the musculoskeletal system, 2745 Rheumatology, Anti-Inflammatory Agents, TNF inhibition, Physical exercise, 610 Medicine & health, Overweight, Anti-Inflammatory Agents/therapeutic use, Cohort Studies, 03 medical and health sciences, 0302 clinical medicine, Female, Humans, Obesity/complications, Spondylarthritis/drug therapy, Treatment Outcome, Tumor Necrosis Factor-alpha/antagonists & inhibitors, Ankylosing spondylitis, Axial spondyloarthritis, Obesity, Internal medicine, Spondylarthritis, medicine, BASDAI, 030203 arthritis & rheumatology, ddc:616, 2403 Immunology, business.industry, Tumor Necrosis Factor-alpha, 10051 Rheumatology Clinic and Institute of Physical Medicine, Odds ratio, medicine.disease, Confidence interval, 030104 developmental biology, Physical therapy, 2723 Immunology and Allergy, medicine.symptom, lcsh:RC925-935, business, Body mass index, Cohort study, Research Article
وصف الملف: s13075-017-1372-3.pdf - application/pdf; application/pdf
-
4
المؤلفون: Cem, Gabay, Michael, Bel, Christophe, Combescure, Camillo, Ribi, Sara, Meier, Klara, Posfay-Barbe, Stéphane, Grillet, Jörg D, Seebach, Laurent, Kaiser, Werner, Wunderli, Pierre-André, Guerne, Claire-Anne, Siegrist, S, Yerly
المساهمون: Gabay, Cem, Bel, Michael, Combescure, Christophe, Ribi, Camillo, Meier, Sara, Posfay Barbe, Klara, Grillet, Stéphane, Seebach, Jorg Dieter, Kaiser, Laurent, Wunderli, Werner, Guerne, Pierre-André, Siegrist, Claire-Anne, Ambrosioni Czyrko, Juan, Berney, Thierry, Calmy, Alexandra, Chalandon, Yves, Charvat-Jackson, Sandrine, Delhumeau-Cartier, Cécile, Desmeules, Jules Alexandre, Dietrich, Pierre-Yves, Favet, Laurence, George, Anne-Claude Catherine, Giostra, Emiliano, Hadaya, Karine, Hirschel, Bernard, Martin, Pierre-Yves, Mentha, Gilles, Mohty, Bilal, Morard, Isabelle, Nagy, M., Nguyen, Alexandra, Noble, Stéphane Laurent, Passweg, Jakob, Roosnek, Eddy Emile, Sealy, Gregg, Gasche-Soccal, Paola Marina Alessandra, Thomas, Yves, Van Delden, Christian, Verdon, Mélanie, Villard, Jean, Yerly Ferrillo, Sabine
المصدر: Arthritis and Rheumatism, Vol. 63, No 6 (2011) pp. 1486-96
مصطلحات موضوعية: Male, Antibody Formation/immunology, ddc:616.07, Antibodies, Viral, Arthritis, Rheumatoid, Influenza A Virus, H1N1 Subtype, ddc:590, Immunology and Allergy, Pharmacology (medical), B-Lymphocytes/drug effects/immunology, ddc:616, B-Lymphocytes, ddc:617, Adjuvants, Immunologic/adverse effects/therapeutic use, Antibody titer, virus diseases, Middle Aged, Influenza A Virus, H1N1 Subtype/immunology, Influenza Vaccines, Rheumatoid arthritis, Antirheumatic Agents, Female, medicine.drug, Adult, Spondylarthritis/drug therapy/immunology, medicine.medical_specialty, Influenza vaccine, Immunology, Rheumatology, Adjuvants, Immunologic, Sulfasalazine, Internal medicine, Spondylarthritis, medicine, Humans, AS03, Adverse effect, Antibodies, Viral/blood/immunology, business.industry, Tumor Necrosis Factor-alpha, Tumor Necrosis Factor-alpha/antagonists & inhibitors, Hydroxychloroquine, Antirheumatic Agents/immunology, Hemagglutination Inhibition Tests, medicine.disease, respiratory tract diseases, Arthritis, Rheumatoid/drug therapy/immunology, Antibody Formation, business, Influenza Vaccines/adverse effects/immunology/therapeutic use